Both in Pharmaceuticals
Trulieve Cannabis vs Zymeworks
Over the past year TRLV returned −1.9% and ZYME returned +10.5%; their daily moves had a correlation of 0.62.
TRLV −1.9% ZYME +10.5%Growth of $1, one year, split-adjusted
| Metric | TRLV | ZYME |
|---|---|---|
| Price | $11.10 | $28.99 |
| Market cap | $2.14B | $2.08B |
| Today | +7.98% | +1.33% |
| 1 month | +3.5% | +15.3% |
| 6 months | — | +8.3% |
| Year to date | — | +10.1% |
| 1 year | — | +51.6% |
| Revenue growth (YoY) | — | −90.6% |
| Gross margin | 59.9% | 100.0% |
| Net margin | −149.8% | −980.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 56.1× |
| Net cash | -$154.8M | $270.7M |
| Dividend yield | — | — |
| Volatility (60d) | — | 46.5% |
| Short % of float | 4.4% | 13.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).